Molecular determinants of α-synuclein toxicity and aggregation revealed by deep mutagenesis
Related Experiment Video
Updated: Nov 4, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Daeun Noh1, Robert W Newberry1
1Department of Chemistry, The University of Texas at Austin, 105 E 24th St. Austin, TX, 78712, U.S.A.
Abstract:
The abundant neuronal protein α-synuclein is a key driver of Parkinson's and related diseases. α-Synuclein adopts a wide variety of different conformational states, but it is often unclear which of these species is responsible for its various behaviors, complicating efforts to combat pathologic misfolding of α-synuclein. Whereas conventional approaches struggle to provide direct, high-resolution insight into these structure-activity relationships, deep mutational scanning (DMS) has recently emerged as a powerful approach to probe the structural basis of protein activity and identify the molecular determinants of pathology. In the present review, we highlight insights from recent DMS studies of α-synuclein, which have implicated membrane binding as an important contribution to its toxicity and aggregation. Further, experiments in different cell types reveal distinct determinants of aggregation, highlighting the role of the cellular environment in shaping the conformational landscape of α-synuclein. We therefore expect that DMS will fill an important gap in the characterization of protein structure-activity relationships, particularly for conformationally dynamic proteins, including those implicated in misfolding diseases.
More Related Videos
08:40Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions
Published on: June 23, 2022
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018